3D Matrices for Anti-Cancer Drug Testing and Development
Authors:
- Lisa A. GurskiLGLisa A. Gurski
- Nicholas J. PetrelliNPNicholas J. Petrelli
- Xinqiao JiaXJXinqiao Jia
- Mary C. Farach-CarsonMFMary C. Farach-Carson
- 1 January 2010
- journal article
- research article
- Published by SLACK, Inc. in Oncology Issues
- Vol. 25 (1) , 20-25
Abstract
(2010). 3D Matrices for Anti-Cancer Drug Testing and Development. Oncology Issues: Vol. 25, No. 1, pp. 20-25.Keywords
This publication has 63 references indexed in Scilit:
- Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cellsBiomaterials, 2009
- New dimensions in tumor immunology: what does 3D culture reveal?Trends in Molecular Medicine, 2008
- Functional electrospun nanofibrous scaffolds for biomedical applicationsAdvanced Drug Delivery Reviews, 2007
- Engineering tumors with 3D scaffoldsNature Methods, 2007
- Modeling Tissue Morphogenesis and Cancer in 3DCell, 2007
- LIFE ISN'T FLAT: TAKING CANCER BIOLOGY TO THE NEXT DIMENSIONIn Vitro Cellular & Developmental Biology - Animal, 2006
- Designing materials for biology and medicineNature, 2004
- Forecasting the growth of multicell tumour spheroids: implications for the dynamic growth of solid tumoursCell Proliferation, 2000
- Review: Hydrogels for cell immobilizationBiotechnology and Bioengineering, 2000
- Effects of nIFN β and rifn γ on growth and morphology of two human melanoma cell lines: Comparison between two‐and three‐dimensional cultureInternational Journal of Cancer, 1994